What Is DSHEA?

The 1994 federal law that defines dietary supplements as a distinct regulatory category and establishes the framework for their manufacture, labelling, and marketing in the United States.

Why It Matters for Supplement Brands

DSHEA is the regulatory foundation for the entire dietary supplement industry in the US. It determines what you can sell, what you can say about it, and what compliance obligations you have. Understanding DSHEA is essential for anyone launching, marketing, or selling supplement products.

How It Works

Before DSHEA, the FDA could regulate supplements as food additives — requiring pre-market approval. DSHEA changed this by:

1. **Defining dietary supplements**: Vitamins, minerals, herbs, amino acids, and other dietary substances intended to supplement the diet. 2. **Shifting the burden of proof**: The FDA must prove a product is unsafe (rather than the manufacturer proving it's safe) for products with pre-DSHEA history of use. 3. **Allowing structure–function claims**: Without FDA pre-approval, provided they're truthful, substantiated, and carry the required disclaimer. 4. **Requiring New Dietary Ingredient (NDI) notifications**: For ingredients not sold before October 15, 1994. 5. **Mandating Good Manufacturing Practices (cGMPs)**: Quality standards for supplement manufacturing.

DSHEA does NOT allow disease claims, health claims, or drug claims on supplement labels without separate FDA authorisation.

Common Mistakes to Avoid

  • Assuming DSHEA means supplements are 'unregulated' — they are regulated, just differently from drugs
  • Not filing NDI notifications for new ingredients
  • Making disease claims and assuming structure–function rules protect you
  • Ignoring cGMP requirements for manufacturing
  • Applying DSHEA rules outside the US — each country has its own supplement regulations

Related Terms

Structure–Function ClaimSubstantiationcGMP (Current Good Manufacturing Practices)New Dietary Ingredient (NDI)

Automate Your Substantiation

Nutra Comp turns weeks of manual research into minutes of automated clinical evidence analysis and FDA-compliant claim generation.

Join the Waitlist